P3 Health Partners (PIII) EBIAT (2020 - 2025)
Historic EBIAT for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to -$69.5 million.
- P3 Health Partners' EBIAT rose 3245.87% to -$69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.6 million, marking a year-over-year decrease of 1445.73%. This contributed to the annual value of -$310.4 million for FY2024, which is 6650.04% down from last year.
- Per P3 Health Partners' latest filing, its EBIAT stood at -$69.5 million for Q3 2025, which was up 3245.87% from -$43.7 million recorded in Q2 2025.
- In the past 5 years, P3 Health Partners' EBIAT ranged from a high of -$24.7 million in Q1 2021 and a low of -$903.1 million during Q2 2022
- For the 5-year period, P3 Health Partners' EBIAT averaged around -$124.3 million, with its median value being -$52.4 million (2023).
- As far as peak fluctuations go, P3 Health Partners' EBIAT crashed by 296507.41% in 2022, and later skyrocketed by 9694.39% in 2023.
- Quarter analysis of 5 years shows P3 Health Partners' EBIAT stood at -$60.2 million in 2021, then crashed by 783.9% to -$532.4 million in 2022, then skyrocketed by 87.02% to -$69.1 million in 2023, then plummeted by 86.91% to -$129.2 million in 2024, then soared by 46.19% to -$69.5 million in 2025.
- Its EBIAT was -$69.5 million in Q3 2025, compared to -$43.7 million in Q2 2025 and -$44.2 million in Q1 2025.